Clinical Trial Update: Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Azadirachta Indica for chronic lymphocytic leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Azadirachta Indica (Azadirachta Indica)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Refractory Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia | Phase 1 | Status: WITHDRAWN